Development of dyskinesias in a 5-year trial of ropinirole and L -dopa-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development of dyskinesias in a 5-year trial of ropinirole and L -dopa

Published:2006-09-06 Issue:11 Volume:21 Page:1844-1850
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov. Disord.

Author:

Rascol Olivier,Brooks David J.,Korczyn Amos D.,De Deyn Peter P.,Clarke Carl E.,Lang Anthony E.,Abdalla Mona

Funder

GlaxoSmithKline Research and Development

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/mds.20988/fullpdf

Reference19 articles.

1. A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. 056 Study Group.;Rascol;N Engl J Med,2000

2. Pramipexole vs levodopa as initial treatment for Parkinson disease. A randomized controlled trial;Parkinson Study Group;JAMA,2000

3. Initial agonist treatment of Parkinson disease: a critique;Albin;Neurology,2003

4. De novo administration of ropinirole and bromocriptine induces less dyskinesia than L-dopa in the MPTP-treated marmoset;Pearce;Mov Disord,1998

Cited by 142 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dopamine agonists in the treatment of Parkinson's disease: the show must go on;Journal of Neural Transmission;2024-09-11

2. Pharmacotherapy of motor symptoms in early and mid-stage Parkinson’s disease: guideline “Parkinson’s disease” of the German Society of Neurology;Journal of Neurology;2024-08-29

3. Levodopa versus levodopa sparing in early parkinson�s disease: can we meet halfway?;Revista de investigaci�n Cl�nica;2024-07-12

4. Comparison of dyskinesia profiles after L-DOPA dose challenges with or without dopamine agonist coadministration;Neuropharmacology;2023-10

5. Parkinson's treatment in perspective. Commentary on Levodopa and dopamine agonists in the treatment of Parkinson's disease by Theodore L. Sourkes and Serge Gauthier;Discoveries in Pharmacology;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3